• 

  Roche Alzheimer’s Drug Fails in Trials
• 

  Alzheon’s Pill For Alzheimer’s Recruits for Clinical Trials
• 

  Blue Pee Fiasco: Alzheimer’s Pill Has Colorful, Complicating Side Effect
• 

  Study: Alzheimer’s Trials Are Basically Designed for White People
• 

  FDA Fast-Tracks Alzheimer’s Drug Lecanemab; Decision Expected By Early 2023
• 

  Meet the Stentrode: A Bluetooth Implant to Give You Mind Control Over Computers
• 

  After 9 Years in Trials, Roche’s Crenezumab Stalls Out
• 

  Alzheimer’s Drug Made of Bone Marrow Moves Through Trials
• 

  Testing a Drug’s Disease-Modifying Potential For Frontotemporal Dementia
• 

  Vaxxinity Wants to ‘Democratize’ Alzheimer’s Treatment With Vaccine
• 

  Global Alzheimer’s Trial For China’s ‘Seaweed Drug’ Halted
• 

  Biogen Abandons Aduhelm Approval Process in Europe 
• 

  What Is Tau — and Why Does It Matter in Alzheimer’s?
• 

  Brain Power: Understanding Bioenergetics, Treating Alzheimer’s
• 

  Targeting Gingivitis-Causing Bacteria to Treat Alzheimer’s

Previous456Next